Previous Article | Next Article ![]()
Infect. Immun., 06 1996, 2041-2046, Vol 64, No. 6
P Ancuta, T Pedron, R Girard, G Sandstrom and R Chaby
We studied the ability of the lipopolysaccharide (LPS) extracted from a
vaccine strain of Francisella tularensis (LPS-Ft) to mimic LPSs from other
gram-negative bacteria for activation of various murine cell types or to
antagonize the effects of other LPSs. We found that activation of
macrophages for the production of tumor necrosis factor alpha and NO, of
pre-B lymphocytes for the expression of surface immunoglobulins, and of
bone marrow cells for the expression of LPS- binding sites was either
undetectable with LPS-Ft or required concentrations 100 to 1,000 times
higher than for standard LPSs. Preexposure of macrophages to LPS-Ft also
failed to trigger down- regulation of tumor necrosis factor alpha
(desensitization) or up- regulation of NO responses to an endotoxin
challenge. In contrast to other atypical LPSs, LPS-Ft was also unable to
antagonize any of the endotoxin-induced cellular responses mentioned above,
suggesting that this LPS does not interact with LPS receptors.
Copyright © 1996, American Society for Microbiology
Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins
Endotoxin Group, URA-1116 of the National Center for Scientific Research, University of Paris-Sud, Orsay, France.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|